Tina Kiang, PhD U.S. FDA

Tina Kiang, Ph.D. currently serves as the Director of the Division of Regulation, Guidance and Standards in OPQ/OPPQ.  She began her career at FDA in 2005 as a chemistry and engineering reviewer in the Division of Ophthalmic and Ear, Nose and Throat Devices (DOED) in CDRH. In 2009, she became branch chief of the Intraocular, Cornea, and Neuromaterials Branch (ICNB), which reorganized in 2012 into the Intraocular and Corneal Implants Branch (ICIB). In 2015, Tina became the Deputy Director of the Division of Anesthesiology, General Hospital, Respiratory, Infection Control, and Dental Devices (DAGRID) and became Acting Director in 2016, prior to the CDRH reorganization. In 2018, when the Office of Product Evaluation and Quality (OPEQ) was established, Tina became the Director of the Division of Drug Delivery and General Hospital Devices and Human Factors (DHT3C) in the Office of Health Technology 3 (OHT3). She received her bachelor of engineering in chemical engineering from The Cooper Union in New York and her Ph.D. in Biomedical Engineering from The Johns Hopkins University School of Medicine.